Navigation Links
Report Reveals Disparities in Pharmaceutical Treatment for Minority Patients
Date:5/12/2009

WASHINGTON, May 12 /PRNewswire-USNewswire/ -- A new report from the National Minority Quality Forum finds that appropriate medications for a variety of diseases often are under-prescribed, over-prescribed, or mis-prescribed for African Americans, Hispanics and Asian Americans. This comprehensive review of studies on medication use in U.S. minority groups, entitled Origins and Strategies for Addressing Ethnic and Racial Disparities in Pharmaceutical Therapy: The Health-Care System, the Provider, and the Patient, reveals disparities in treatment of minority patients with cardiovascular illness, asthma, psychiatric illness, pain and other conditions.

The report, authored by Richard Levy, Ph.D., Robert C. Like M.D., M.S., and Harry S. Shabsin, Ph.D., finds disparities in access to medications through insurance programs, in the prescribing of medications and in adherence to medication regimens. The report offers recommendations for health-care planners and advocates, clinicians and health-care organizations to improve prescribing and use of medications in a diverse society.

"Since medications are a cornerstone of treatment for many diseases, addressing unequal or inappropriate medication use should be a focus for practitioners and organizations committed to the goal of eliminating health-care disparities. We hope this report raises awareness of the extent of medication disparities and will stimulate solutions to address the problem," said Dr. Like, Professor and Director of the Center for Healthy Families and Cultural Diversity of the UMDNJ-Robert Wood Johnson Medical School.

The report points out that improving access to and use of medications in diverse groups requires policies that enable affordable, personalized therapy. Ethnic/racial background should, like other factors such as age or gender, be considered in selecting drugs and dosages, in the composition of drug formularies and preferred drug lists, and in determining the scope of drug substitution policies. The report emphasizes that therapy must be tailored to individual needs and stereotyping and overgeneralization in caring for diverse populations should be avoided.

Dr. Levy, a health care consultant and former vice president of the National Pharmaceutical Council, states: "Differences in response to pharmaceuticals in minority populations indicate the importance of including diverse groups in comparative-effectiveness assessments. Failure to do so may reduce, rather than improve, the quality of care for ethnic and racial minorities".

Key Findings from the Report

  • Many studies have revealed ethnic/racial disparities in prescribing (under-prescribing, over-prescribing or mis-prescribing) for specific diseases or classes of medication, including medications for asthma, depression, psychosis, cardiovascular disease, diabetes, pain and infectious disease.
  • Medication disparities can stem from a relative lack of health and drug insurance, aggressive cost containment in pharmacy benefits plans and reduced services at pharmacies in minority neighborhoods. All of these situations can limit access to medications or cause patients to reduce or discontinue therapy.
  • Most state Medicaid programs utilize pharmaceutical cost containment polices which include prior authorization, generic substitution, preferred drug lists, copayments and caps. While fulfilling their intent to save drug costs, these policies may have the unintended consequences of limiting access to necessary medications. This limitation has been associated with increased utilization of medical services by minority patients.
  • Suboptimal prescribing may reflect a clinician's lack of knowledge about the patient's culture or to the clinician's beliefs about that culture. Clinicians who have that knowledge and who communicate well can positively affect treatment outcomes.
  • Relatively low adherence in filling initial prescriptions, refilling prescriptions and taking medications according to directions has been reported in minority patients being treated for asthma, depression, psychosis, cardiovascular diseases, osteoporosis, diabetes and in receiving vaccinations. Low medication adherence in minority populations has been correlated with reduced health status.
  • Much of the association between race/ethnicity and low adherence is explained by low household income, lack of insurance, poor education, low health literacy, language barriers and cultural beliefs. Low adherence may also reflect poor communication by providers, often due to lack of cultural competence training and time/resource constraints.
  • Use of herbal or other folk remedies by persons from various cultural backgrounds can complicate, interact and sometimes detract from treatment with western medicines.
  • Response to medications and optimal dosages may differ due to genetic or environmental factors, or diet. Ethnic differences have been consistently reported in the metabolism, effectiveness and frequency of side effects of many important drugs. Failure to account for these differences when prescribing or selecting agents for formularies or preferred drug lists may lead to suboptimal treatment and disparities.

The report is available online at http://store.nmqf.org/p-13-nmqf-e-books.aspx.

The National Minority Quality Forum (NMQF) (http://www.nmqf.org) is a nonprofit, nonpartisan organization research and educational organization dedicated to ensuring that high-risk racial and ethnic populations and communities receive optimal health care. NMQF integrates data and expertise in support of initiatives to eliminate health disparities.


'/>"/>
SOURCE National Minority Quality Forum
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Participants in antidepressant drug trials are atypical patients, UT Southwestern researchers report
2. Smart Phone, ePRO, and eDiary Technology Advances for Clinical Trials, Market Research, and Registries Reported by assisTek
3. Body movements can influence problem solving, researchers report
4. NCPA Briefing Raises Questions About Trustees Annual Report
5. Two New Reports Highlight Stalled Progress Against Diarrheal Disease: Nearly 1.6 Million Children Die Each Year From These Preventable and Treatable Diseases
6. Cancer Caregiver Distress Unrecognized and Under Reported
7. Cardium Reports on First Quarter 2009 Financial Results and Recent Developments
8. Vion Pharmaceuticals Reports 2009 First Quarter Results
9. Medivation Reports First Quarter 2009 Financial Results and Provides Corporate Update
10. Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46
11. Swine flu: Early findings about pandemic potential reported in new study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... , ... The Radiology Business Management Association will select the 2017 ... Building Better Radiology Marketing Programs conference, held this year from March 5 ... awards are given out in five categories. They are:, ,     Patient ...
(Date:2/23/2017)... ... 23, 2017 , ... On February 22, 2017 the U.S. ... to withdraw previous guidance issued by the Obama Administration requiring schools to treat ... 2016 by the Obama Administration came in response to a growing number of ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Los Angeles-based ... episodes of WE TV’s “Mama June: From Not to Hot,” which will begin airing ... “Mama” June Shannon, known to millions from the 2012 reality television series, “Here Comes ...
(Date:2/23/2017)... ... February 23, 2017 , ... Dr. David Mahon leads Siena Dental, ... Dr. Mahon was named a 2017 Top Patient Rated Henderson Dentist by ... directory that recognizes local physicians and dentists who have earned high ratings and superior ...
(Date:2/23/2017)... Lincoln, RI (PRWEB) , ... February 23, 2017 ... ... announced today a new partnership with the Rhode Island Consortium for Autism Research ... provide an opportunity for children with autism spectrum disorder (ASD) to see films ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... leading the discovery and development of innovative medicines targeting ... full year 2016 financial results on Thursday, March 2, ... host a conference call and webcast on March 2, ... quarter and full year 2016 financial results and provide ...
(Date:2/23/2017)... ... Research and Markets has announced the addition of the "Global ... report to their offering. The Global Antifungal Drugs Market ... next decade to reach approximately $12.8 billion by 2025. ... the given segments on global as well as regional levels presented in ...
(Date:2/23/2017)... Ga., Feb. 23, 2017  MiMedx Group, Inc. (NASDAQ: ... tissue and patent-protected processes to develop and market advanced ... Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, ... and full year ended December 31, 2016. ... Revenue is a 31% increase over full year 2015 ...
Breaking Medicine Technology: